Pibrentasvir

Overview

Pibrentasvir is a novel and pan-genotypic hepatitis C virus ( HCV ) NS5A inhibitor with EC 50 s ranging from 1.4 to 5.0 pM against HCV replicons containing NS5A from genotypes 1 to 6.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Hepatitis Virus Infection | Products > Disease Areas > Viral Infection | Products > Disease Areas > Hepatitis C Virus Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HCV

Product Information

• Catalog No.: HY-101662
• CAS No.: 1353900-92-1
• Molecular Formula: C57H65F5N10O8
• Molecular Weight: 1113.18
• Purity: 99.94%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (2.25 mM); Clear solution
• Availability: In-stock

Source

Original product source